Favipiravir shows significant improvement in time to clinical cure for mild to moderate COVID-19
These findings were observed in Phase 3 clinical trial conducted by Glenmark Pharmaceuticals and have been published by the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
FabiFlu
Glenmark to launch FabiFlu (400 mg) for COVID-19 treatment
With the new 400 mg version, patients need to consume nine tablets on Day 1, and thereafter two tablets twice a day from Day 2…
Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India:…
Both drugs have seen a sharp decline in price since the availability of the first generic in India
Haryana FDA files FIR against foreign nationals for illegal export of COVID-19 drugs
The team also seized drugs containing narcotic and psychotropic substances
FabiFlu more affordable than other drugs: Glenmark to DCGI
The company also sends its justifications and clarifications to allegations of false claims about FabiFlu’s use for COVID-19…
DCGI queries pharma company on its claim of FabiFlu use for COVID-19 patients with comorbidities
As per statement by the Glenmark and media reports, the DCGI had accelerated the process for clinical trials and reviews…
Glenmark Pharma cuts price of COVID-19 drug by 27 pc to Rs 75/tablet
Glenmark Pharmaceuticals had launched FabiFlu last month at a price of Rs 103 per tablet
Maha govt plans to procure 10000 vials of remdesivir from Cipla
It also plans to procure favipiravir from Glenmark
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir
Over 10 leading government and private hospitals in India are being enrolled for the study, Glenmark estimates study completion by…